Funding for this research was provided by:
The Wellcome Trust (096527)
Bill and Melinda Gates Foundation (OPP1132628)
Received: 26 April 2019
Accepted: 16 November 2019
First Online: 27 November 2019
Ethical approval and consent to participate
: The TACT-CV trial was registered on clinicaltrials.gov: NCT03355664 on the 28th of November 2017. The trial was approved by the Cambodian National Ethics Committee on Health Research (NECHR) reference 210, renewed 23rd February 2018, and Oxford Tropical Research Ethics Committee (OxTREC) approval reference: 32-17, 30th November 2017. All respondents gave informed consent prior to participation. Written consent at the time of enrolment into a malaria treatment study, for those who were enrolled as malaria patients. For the interviews reported in this paper, verbal consent was obtained at the time of IDIs and from their peers during FGDs. In this research we adhered to the European Anthropological Association Code of Ethics.
: Not applicable.
: The authors declare that they have no competing interests.